Enzymatic determination of urinary glycosaminoglycans from orthopedic patients.
Crude glycosaminoglycan (GAG) fraction was directly precipitated with cetylpyridinium chloride without prior dialysis of urine of orthopedic patients. The crude GAG fraction was then fractionated with trichloroacetic acid (TCA). The TCA-insoluble peptide-bound GAG fraction thus obtained was treated with alkali to eliminate the peptide moiety for enzymatic analysis. The GAG compositions of this fraction and the TCA-soluble fraction were determined by digestion with mucopolysaccharidases (chondroitinase AC, chondroitinase B, chondroitinase C, heparitinase and Streptomyces hyaluronidase). When the amount of the crude GAG fraction was small, no significant amount of the TCA-insoluble peptide-bound GAG fraction was obtained. The GAG composition of this case was also determined by the same procedures after direct alkali-treatment of the crude GAG fraction. The data indicated that the proportion of the TCA-insoluble peptide-bound GAG fraction was very small. The alkali-treated TCA-insoluble peptide-bound GAG fraction contained a larger proportion of heparan sulfate than the TCA-soluble GAG fraction. It was clearly demonstrated that the patients with Werner's syndrome and mucopolysaccharidosis I-S (Scheie) excreted large amounts of hyaluronic acid and dermatan sulfate respectively, into urines. It was indicated in most cases that major urinary GAG were chondroitin 4-sulfate, chondroitin 6-sulfate plus chondroitin and heparan sulfate, while minor ones were dermatan sulfate and hyaluronic acid. In addition, the data suggested a wide range of the degree of desulfation or urinary GAG, and the presence of significant amounts of keratan sulfate plus acidic glycopeptides in the urinary GAG fractions. The present data provided more precise information on urinary GAG from orthopedic patients than those reported previously.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001847:Bone Diseases / Q000652:urine*; D005591:Chemical Fractionation; D002809:Chondroitin Sulfates / Q000652:urine; D003871:Dermatan Sulfate / Q000652:urine; D005260:Female; D005966:Glucuronidase / Q000378:metabolism; D006025:Glycosaminoglycans / Q000652:urine*; D006497:Heparan Sulfate / Q000652:urine; D006801:Humans; D006820:Hyaluronic Acid / Q000652:urine; D008190:Lyases / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D008059:Mucopolysaccharidosis I / Q000652:urine; D014898:Werner Syndrome / Q000652:urine
D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D005966:Glucuronidase; D006025:Glycosaminoglycans; D006497:Heparan Sulfate; D006820:Hyaluronic Acid; D008190:Lyases; C021812:mucopolysaccharidase